Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Chest|November 19, 2019
Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway AgentsVallerie V McLaughlin, Richard Channick, Teresa De Marco, et al.
American Journal of Respiratory and Critical Care Medicine|March 4, 2025
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in <i>BMPR2</i> Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)David Montani, Vallerie V McLaughlin, J Simon R Gibbs, et al.
BMC Pulmonary Medicine|December 29, 2017
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access studyVallerie V McLaughlin, Pavel Jansa, Jens E Nielsen-Kudsk, et al.
The Lancet. Respiratory Medicine|February 23, 2025
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patientsFranck F Rahaghi, Marc Humbert, Marius M Hoeper, et al.
The European Respiratory Journal|September 11, 2023
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trialRogerio Souza, David B Badesch, H Ardeschir Ghofrani, et al.
The New England Journal of Medicine|August 27, 2015
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial HypertensionNazzareno Galiè, Joan A Barberà, Adaani E Frost, et al.
Journal of the American College of Cardiology|February 16, 2018
Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for MortalityVallerie V McLaughlin, Marius M Hoeper, Richard N Channick, et al.
The New England Journal of Medicine|March 6, 2023
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionMarius M Hoeper, David B Badesch, H Ardeschir Ghofrani, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 7, 2024
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLARMardi Gomberg-Maitland, David B Badesch, J Simon R Gibbs, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
Pageof 17